| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |